Molecular biological analysis of mechanisms of interleukin-8 production, with a refernce to the roles of reactive oxygen
参考活性氧的作用,对 IL-8 产生机制进行分子生物学分析
基本信息
- 批准号:06670346
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
First, we investigated the roles of reactive oxygen species in interleukin-8 (IL-8) gene activation by adding several anti-oxidants to human monocytic cell line, THP-1 stimulated with lipopolysaccahride (LPS). The activation of a transcription factor, NF-kappaB,was indispensable for LPS-induced IL-8 gene activation in THP-1 cells, as observed on other types of cells. However, when we added anti-oxidants to intact cells, we failed to observe any inhibition on IL-8 gene activation as well as NF-kappaB activation.We postulated that low-permeability of these anti-oxidants might account for their failure to inhibit IL-8 gene activation. Thus, by using cell extracts from THP-1 cells, we developed a cell-free system where NF-kappaB can be detected. In this system, we can add various types of inhibitors without considering their permeability or potential toxicity. Using this system, we observed that IkappaBalpha, an inhibitor of NF-kappaB,was phosphorylated before NF-kappaB activation. Moreove … More r, the subsequent degradation of IkappaBalpha was not observed in this system. Furthermore, two distinct types of protein kinases, staurosporine-sensitive one (s) and tyrosine kinase (s), were involved in NF-kappaB activation whereas tyrosine kinase inhibitors but not staurosporine inhibited the phosphorylation of IkappaBalpha.In order to clarify the mechanism of NF-kappaB activation, we tried to characterize the IkappaBalpha phosphorylase. In response to LPS,partially purified IkappaBalpha kinase rapidly phosphorylated serine and threonine residues present in the carboxy-terminal acidic region of IkappaBalpha, particularly, Ser293. The peptide corresponding to this region inhibited NF-kappaB activation as well as IkappaBalpha phosphorylation in a cell-free system, indicating that the phosphorylation of this site is indispensable for these processes. Collectively, these results suggest the mechanisms of LPS-induced IL-8 gene activation as follows :LPS activates two types of kinases, tyrosine kinase (s) and staurosporine-sensitive one (s). Activated tyrosine kinase activates IkappaBalpha kinase, which in turn phosphorylates mainly serine residues present in the carboxy-terminal acidic region of IkappaBalpha. NF-kappaB dissociate from phosphoryalted IkappaBalpha, thereby translocating into nucleus and binding the corresponding cis-element. Staurosporine-sensitive kinase (s) may participate in NF-kappaB activation by phosphorylating the components of NF-kappaB.In paralled with these experiments, we also analyzed the molecular mechanisms of IL-8 gene repression by several agents such as FK506, a glucocorticoid, and interferon alpha/beta. We observed that these agents attenuated the NF-kappaB activation although the mechanisms were slightly different from each agent. These results raised the possibilities that the drug targeting NF-kappaB activation may be a good candidate for an anti-inflammatory agent by inhibiting the production of a potent neutrophil chemotactic cytokine, IL-8. Furthermore, our cell-free system to detect NF-kappaB activation will be useful for screening this kind of agents. Less
首先,我们通过在人单核细胞系中添加几种抗氧化剂,研究了活性氧中的活性氧在白介素8(IL-8)基因激活中的作用,该细胞细胞系被脂肪polysaccahride(LPS)刺激的THP-1。在THP-1细胞中LPS诱导的IL-8基因活化是必不可少的,如在其他类型的细胞上,对于LPS诱导的IL-8基因激活是必不可少的。但是,当我们在完整细胞中添加抗氧化剂时,我们无法观察到对IL-8基因激活以及NF-kappab激活的任何抑制作用。通过使用THP-1细胞中的细胞提取物,我们开发了一个无细胞的系统,可以检测到NF-kappab。在该系统中,我们可以在不考虑其渗透性或潜在毒性的情况下添加各种类型的抑制剂。使用该系统,我们观察到NF-kappab的抑制剂Ikappabalpha在NF-kappab激活之前被磷酸化。 Moreove…更多的R,在该系统中未观察到Ikappabalpha的随后降解。此外,NF-kappab激活参与了两种不同类型的蛋白激酶,星形孢菌素敏感的一种和酪氨酸激酶,而酪氨酸激酶抑制剂,但不是staurosporine抑制剂。为了响应LP,部分纯化的Ikappabalpha激酶快速磷酸化的丝氨酸和苏氨酸保留在Ikappabalpha的羧基末端酸性区域中,尤其是SER293。该肽对应于该区域抑制了无细胞系统中的NF-kappab激活以及ikappabalpha磷酸化,这表明该位点的磷酸化对于这些过程是必不可少的。总的来说,这些结果表明LPS诱导的IL-8基因激活的机制如下:LPS激活两种类型的激酶,酪氨酸激酶(S)和符号孢菌素敏感的一种。活化的酪氨酸激酶激活了Ikappabalpha激酶,进而将丝氨酸磷酸化主要保留在Ikappabalpha的羧基末端酸性区域中。 NF-kappab与磷酸化的ikappabalpha分离,从而易位成核并结合相应的顺式元素。与这些实验并行的NF-kappab的成分,可以通过磷酸化NF-kappab的激活来参与NF-kappab的激活,我们还分析了几种Ass fk506(例如FK506),一种glucoforoidoinoid alpha和Interstra和Interstra和Internerpha,我们还分析了IL-8基因表达的分子机制。我们观察到这些试剂减弱了NF-kappab的激活,尽管这些机制与每个药物略有不同。这些结果提高了靶向NF-kappab激活的药物可能通过抑制潜在的中性粒细胞趋化细胞因子IL-8的产生而成为抗炎剂的良好候选者。此外,我们检测NF-kappab激活的无细胞系统将有助于筛选这种药物。较少的
项目成果
期刊论文数量(66)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Okamoto, S.-i.: "The interleukin-8 AP-1 and kB-like sites are genetic end targets of FK506-sensitive pathway accompanied with calcium mobilization." J Biol. Chem.269. 8582-8589 (1994)
Okamoto, S.-i.:“IL-8 AP-1 和 kB 样位点是伴随钙动员的 FK506 敏感途径的遗传最终靶标。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mukaida, N.: "Molecular msechanism of interleukin8 (IL-8) gene expression." J.Leukocyte Biol.56. 554-558 (1994)
Mukaida, N.:“白细胞介素 8 (IL-8) 基因表达的分子机制。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mukaida,N.: "Novel mechanism of qlucocortiocid-mediated gene repression:nuclear factor kB is target for glucocortiocid-mediated interleukin 8 gene repression." J. Biol. Chem.269. 13289-13295 (1995)
Mukaida,N.:“糖皮质激素介导的基因抑制的新机制:核因子 kB 是糖皮质激素介导的白细胞介素 8 基因抑制的目标。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mukaida,N.: "Molecular msechanism of interleukin8 (IL-8) gene expression." J.Leukocyte Biol.56. 554-558 (1994)
Mukaida,N.:“白细胞介素 8 (IL-8) 基因表达的分子机制。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuno,K.: "Identification of an IkBa-associated protein kinese in a human monocyte cell line and determination of its phosphorylation sites of IkBa." J. Biol. Chem.270. 27914-27919 (1994)
Kuno,K.:“鉴定人类单核细胞系中的 IkBa 相关蛋白激酶并确定其 IkBa 磷酸化位点。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MUKAIDA Naofumi其他文献
Crucial contribution of CCL3-CCR5 axis, to murine chronic colitis-associated fibrosis/carcinogenesis
CCL3-CCR5轴对小鼠慢性结肠炎相关纤维化/癌变的关键贡献
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
SASAKI Soichiro;BABA Tomohisa;MUKAIDA Naofumi - 通讯作者:
MUKAIDA Naofumi
MUKAIDA Naofumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MUKAIDA Naofumi', 18)}}的其他基金
Elucidation of the roles of tumor necrosis factor and chemokines in inflammation-associated carcinogenesis
阐明肿瘤坏死因子和趋化因子在炎症相关癌发生中的作用
- 批准号:
21390117 - 财政年份:2009
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the roles of tumor necrosis factor and chemokines in inflammation-associated carcinogenesis
阐明肿瘤坏死因子和趋化因子在炎症相关癌发生中的作用
- 批准号:
19390112 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of a novel tumor marker(s), based on the comprehensive analysis of genes expressed selectively in micometastais site.
基于对微转移位点选择性表达的基因的综合分析,鉴定新的肿瘤标志物。
- 批准号:
16390163 - 财政年份:2004
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel diagnostic method for early detection of chronic liver diseases through the molecular pathological analysis of chronic liver disease models
通过慢性肝病模型的分子病理分析开发一种早期检测慢性肝病的新诊断方法
- 批准号:
11470516 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathophyiological and immunopharmacological studies on chemokines and their receptors
趋化因子及其受体的病理生理学和免疫药理学研究
- 批准号:
10044254 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Development of assay systems for chemokines and their receptors and establishment of their diagnostic value
趋化因子及其受体测定系统的开发及其诊断价值的确立
- 批准号:
10557249 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of an immunoassay system for monocyte chemotacticand activating factor (MCAF) and its clinical application
单核细胞趋化激活因子(MCAF)免疫检测体系的建立及其临床应用
- 批准号:
04671430 - 财政年份:1992
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Aurora-A/NF-KappaB/NRF-2信号轴激活抑制铁死亡介导肝细胞癌Anti-PD-1/PD-L1治疗耐药性产生的机制研究
- 批准号:82272807
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
Aurora-A/NF-KappaB/NRF-2信号轴激活抑制铁死亡介导肝细胞癌Anti-PD-1/PD-L1治疗耐药性产生的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:
RADX突变体通过基因组损伤激活NF-kappaB信号导致单基因炎症性肠病的机制研究
- 批准号:32100735
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
RADX突变体通过基因组损伤激活NF-kappaB信号导致单基因炎症性肠病的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于TLR4/NF-kappaB信号通路金粟兰属药用植物中抗炎免疫的物质基础和作用机制研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
NF-kappaB 和线粒体信号作为炎症的正向和负向调节剂
- 批准号:
10516935 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
脓毒症新疾病驱动因素、治疗靶点和生物标志物的鉴定
- 批准号:
484160 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Operating Grants
Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
脓毒症新疾病驱动因素、治疗靶点和生物标志物的鉴定
- 批准号:
494277 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Operating Grants
The role of NFkB in calcineurin inhibitor-induced renal fibrosis
NFkB 在钙调神经磷酸酶抑制剂诱导的肾纤维化中的作用
- 批准号:
10463002 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Alternative NF-kB activation in post-chemotherapy setting to elucidate novel mechanisms of ovarian cancer relapse
化疗后的替代性 NF-kB 激活可阐明卵巢癌复发的新机制
- 批准号:
10677542 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别: